Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07673250 · ClinicalTrials.gov registry record · NA

Personalized Ventilator Settings for Patients on ECMO

A NA study, sponsored by University of California, San Diego.

Not yet
Registry status
NA
Development phase
62
Enrollment target

NCT07673250: Clinical Trial NA study, sponsored by University of California, San Diego.

NCT07673250 is a NA study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07673250, a NA study, has not yet begun recruiting, sponsored by University of California, San Diego.

NOT YET RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

While mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS). Using extracorporeal membrane oxygenation (ECMO), the highest level of life support also known as the heart-lung machine, investigators may minimize injury from mechanical ventilation to allow the lungs to heal; however, the optimal ventilator strategies while on ECMO are unknown. This study will evaluate personalized ventilator strategy compared to standard of care ventilation.

Interventions

  • DEVICE Personalized Positive End-Expiratory Pressure (PEEP)

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2026-09-01
Est. Completion 2031-06-30
Phase NA
University of California, San Diego

775 total trials

What is known before NCT07673250 opens enrollment

NCT07673250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Personalized Positive End-Expiratory Pressure (PEEP) is the first listed.

NCT07673250 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07673250 about?

NCT07673250 is a clinical study titled "Personalized Ventilator Settings for Patients on ECMO". While mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS). Using extracorporeal membrane oxygenation (ECMO), the highe...

What is the current status of trial NCT07673250?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2026-09-01. Estimated completion is 2031-06-30.

What interventions are being tested in trial NCT07673250?

The interventions under investigation include: Personalized Positive End-Expiratory Pressure (PEEP) (DEVICE).

Who is sponsoring clinical trial NCT07673250?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07673250's enrollment target sits among peer trials

62 1157th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07673250, the US trial registry maintained by the National Library of Medicine. NCT07673250 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.